SCHEMBL24251415

SCHEMBL24251415

Cc1nn2c(C(C)C)cc(C(=O)N[C@H]3CCc4ccccc43)cc2c1-c1cc(Cl)cc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 4/20 0.46
▸ TAS1R1 Q7RTX1 4/20 0.46
▸ TAS1R2 Q8TE23 2/20 0.44
▸ PDE4A P27815 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ PDE4C Q08493 1/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ CRHBP P24387 1/20 0.43
▸ CRHR2 Q13324 1/20 0.43
▸ CNR1 P21554 2/20 0.43
▸ HTT P42858 1/20 0.42
▸ LMNA P02545 2/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ SLC5A7 Q9GZV3 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24251361 0.87 NTRK1 (0.38) TAS1R3TAS1R1TAS1R2SMN1; SMN2CRHBP
SCHEMBL24251444 0.84 TAS1R3 (0.44) TAS1R3TAS1R1TAS1R2SMN1; SMN2CRHBP
SCHEMBL24251368 0.74 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2SMN1; SMN2CRHBP
SCHEMBL24251369 0.74 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2SMN1; SMN2CRHBP
SCHEMBL30373745 0.73 CHRM4 (0.48) TAS1R3TAS1R1TAS1R2SMN1; SMN2CRHBP
SCHEMBL22077539 0.73 CHRM4 (0.48) TAS1R3TAS1R1TAS1R2SMN1; SMN2CRHBP
SCHEMBL31171097 0.72 PDE2A (0.48) TAS1R3TAS1R1TAS1R2SMN1; SMN2CRHBP
SCHEMBL24251449 0.71 BRD4 (0.38) TAS1R3TAS1R1TAS1R2
SCHEMBL24251550 0.70 PDE2A (0.42) TAS1R3TAS1R1TAS1R2PDE4APDE4B
SCHEMBL24251374 0.69 TAS1R3 (0.49) TAS1R3TAS1R1TAS1R2CNR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048903-A1 Anthelminthic Heterocyclic Compounds BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048903-A1 Anthelminthic Heterocyclic Compounds SDHA, PAH, PIGS TAS1R3 4103/4885TAS1R1 3604/4885TAS1R2 3646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback